Mabxience Sets Out Investment Plans Under Fresenius Ownership

New Bioreactor At Genhelix Site In Spain Is A Milestone For Biosimilars Developer

 
• By David Wallace
  
Capacity building
mAbxience is expanding capacity at its Genhelix site • Source: Shutterstock

More from Manufacturing

More from Business